Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012)

Iridex (IRIX) posted Liabilities from Discontinued Operations of $67000.0 for Q3 2012, down 15.19% on a QoQ basis from $79000.0 in Q2 2012.

Analysis

Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012) Analysis & Trends

Iridex has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at $67000.0 in Q3 2012.

On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to $67000.0 in Q3 2012; TTM through Sep 2012 was $67000.0, a N/A change from a year earlier, with the FY2011 full-year figure at $2.7 million, changed N/A from the prior year.
Liabilities from Discontinued Operations was $67000.0 for Q3 2012 at Iridex, down from $79000.0 in the prior quarter.
The five-year high for Liabilities from Discontinued Operations was $2.7 million in Q4 2011, with the low at $67000.0 in Q3 2012.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn
10	Iridex	11.85 Mn	7.17 Mn	4.30 Mn

Historic Data

Download Data